REGULATED PRESS RELEASE published on 06/04/2025 at 07:00, 9 months 18 days ago Biophytis announces its participation in the BIO International Convention from June 16 to 19 Biophytis announces participation in BIO International Convention from June 16 to 19, 2025 in Boston, USA. Focus on drug candidate BIO101 and potential partnerships Biophytis Biotechnology Partnerships BIO International Convention Drug Candidate
REGULATED PRESS RELEASE published on 06/04/2025 at 07:00, 9 months 18 days ago Biophytis annonce sa participation à la BIO International Convention du 16 au 19 juin Biophytis participera à la BIO International Convention du 16 au 19 juin 2025 à Boston, USA, pour présenter ses avancées et son candidat médicament BIO101 Biophytis Biotechnologie Boston BIO International Convention Maladies Liées À L'âge
BRIEF published on 05/30/2025 at 22:05, 9 months 23 days ago Biophytis reporte la publication de ses comptes annuels 2024 Biophytis Assemblée Générale Comptes Annuels Audit Report
BRIEF published on 05/30/2025 at 22:05, 9 months 23 days ago Biophytis Delays 2024 Annual Financial Report Publication Financial Statements Biophytis Shareholder Meeting Age-related Diseases Audit Delay
REGULATED PRESS RELEASE published on 05/30/2025 at 22:00, 9 months 23 days ago Information sur les comptes annuels Biophytis reporte la publication des comptes annuels 2024 en raison de complications techniques dans le processus d'audit. L'assemblée générale des actionnaires est également repoussée Biophytis Assemblée Générale Comptes Annuels Audit Report
REGULATED PRESS RELEASE published on 05/30/2025 at 22:00, 9 months 23 days ago Information on the Annual Financial Statements Biophytis postpones the publication of its 2024 annual financial statements due to technical complications in the audit process. The Company aims to complete the audit by the end of June 2025 Biophytis Audit Postponement 2024 Annual Financial Statements Technical Complications
PRESS RELEASE published on 05/30/2025 at 21:59, 9 months 23 days ago Information sur les comptes annuels Biophytis reporte la publication de ses comptes annuels 2024 en raison de complications techniques dans l'audit. L'assemblée générale est également reportée. La société se concentre sur le développement de traitements pour les maladies liées à l'âge Biophytis Développement Comptes Annuels Report Maladies Liées À L'âge
PRESS RELEASE published on 05/30/2025 at 21:59, 9 months 23 days ago Information on the Annual Financial Statements Biophytis postpones 2024 annual financial statements publication due to technical audit issues, reschedules General Meeting of shareholders following legal procedures Shareholders Financial Statements Biophytis Meeting Audit
BRIEF published on 05/15/2025 at 07:05, 10 months 7 days ago Biophytis présente une avancée dans le traitement de l'obésité à l'ECO 2025 Biophytis Essai Clinique BIO101 Obésité GLP-1
BRIEF published on 05/15/2025 at 07:05, 10 months 7 days ago Biophytis Unveils Promising Obesity Treatment at ECO 2025 Biophytis Clinical Trials Obesity Treatment BIO101 ECO 2025
Published on 03/23/2026 at 02:00, 2 hours 58 minutes ago FutureGen Industries Announces Open Market Investments
Published on 03/20/2026 at 13:30, 2 days 15 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/23/2026 at 03:35, 1 hour 23 minutes ago Deye 2026 Frankfurt Distributor & Partner Summit Concludes Successfully
Published on 03/22/2026 at 12:23, 16 hours 35 minutes ago Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 2 days 6 hours ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 2 days 7 hours ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 19:00, 2 days 9 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 9 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 10 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 10 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
